Daniel Cervelló

Principal Scientist at MRM Health NV

Daniel Cervelló has worked in various roles in the scientific and engineering fields since 2014. In 2014, they began as a Wastewater Treatment Plant and Utilities Engineer at Clariant. In this role, they supervised and monitored the WWTP and Utilities plant, managed data with SAP-QM, and updated analytical procedures according to the latest ISO version. In 2015, they worked as a Wastewater Treatment Plant and Utilities Project Engineer at Clariant, where they developed and validated an ASM3 model of the wastewater treatment plant for the COD removal and simulated model-based increased-load scenarios to determine the optimal performance of the WWTP under the present configuration. In the same year, they also worked as a Bioprocess Scientist/Engineer at Bioera SL, where they developed and optimized microbial (aerobic bacteria and filamentous fungi) fermentation processes, both batch and fed-batch modes in small and bench scale (up to 5L). Daniel also designed scale-up and transferred fermentation processes from lab scale to pilot plant (200L) and pre-production (2000L), as well as developed and optimized downstream processes, including separation and drying. In 2016, they worked as a Graduate Research Intern at TecnATox, Chemical Engineering School, Universitat Rovira i Virgili, where they researched the effect of iron oxide as a photocatalyzer on the photodegradation of Polycyclic Aromatic Hydrocarbons (PAH) by means of GC-MS and identified metabolites produced as a result of PAH decomposition. Finally, they are currently working as a Principal Scientist at MRM Health since 2022.

Daniel Cervelló completed their Bachelor of Science in Biotechnology from Universitat Rovira i Virgili in 2015, followed by a Master of Science in Environmental Engineering and Sustainable Production from the same university in 2016.

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


MRM Health NV

MRM Health NV is a biopharmaceutical company focused on the discovery and development of therapeutics based on the human microbiome.


Headquarters

Ghent, Belgium

Employees

11-50

Links